Med-tech firm NeoChord tops off latest round with another $7 million

//Med-tech firm NeoChord tops off latest round with another $7 million

Med-tech firm NeoChord tops off latest round with another $7 million

NeoChord's technology treats patients who suffer from mitral valve regurgitation, a condition that can cause blood to flow backward into the heart.

Article by [author-name] (c) Technology News - Technology News Headlines | Bizjournals.com - Read full story here.

By | 2019-04-30T15:00:18+00:00 April 30th, 2019|Technology|

About the Author: